URGEFEN-M50

URGEFEN-M50 is the same dual-action pairing as URGEFEN-M25 with the higher mirabegron strength. Solifenacin 5 mg and mirabegron 50 mg, tablets, pack of 10, MRP ₹492.19, once daily. The indications match the sister page: overactive bladder with urgency, frequency, and nocturia, and improved daily micturition in mild to moderate symptoms. The lead does not repeat the words “mild to moderate” in the same place the 25 mg lead does. It says the higher mirabegron strength, for urgency, frequency, and nocturia. Read that difference instead of sanding it down. The 25 mg page is where “mild to moderate” is doing the labelling. This page is where 50 mg is named.

Use this photograph only for this strength. The 25 mg pack has its own carton. A cropped image that hides the 50 is a false M25. The prices are close enough to tempt a shortcut — ₹398.44 against ₹492.19 — and far enough that a wrong strip is an obvious loss as well as a clinical one. Both are packs of 10 tablets, both once daily, both solifenacin 5 mg. The only compositional difference is 25 mg versus 50 mg of mirabegron. Say it every time. The names M25 and M50 exist so you can say it briefly. They do not exist so you can say “Urgefen” and hope.

Nothing in the alpha-blocker family is a substitute explanation. Patients with BPH and overactive bladder may appear in the same clinic, which is why both families live in urology. They are not sequential steps on one page. SILUTS and TALUTS talk about stream, prostate size, and IPSS. URGEFEN talks about urgency, frequency, nocturia, and daily micturition. If your letter needs both, it needs two quantified lines. The preview cart will total ₹492.19 times the quantity of M50 and whatever else you added. The total is not a regimen. SENSIMIST’s mention of overactive bladder is about oral comfort during that care, not about replacing mirabegron.

Once daily, pack of 10, MRP with paise, photograph of the real pack. That is the supply sentence. The house does not print a titration schedule here. Do not author one in the footer of a slide and attribute it to Medrhans. Physicians who step between 25 mg and 50 mg are using their own judgement on top of two published strengths. The catalogue’s job is to keep those strengths unmixed. Mansoorabad’s job is to confirm that the strength you named is the strength that leaves the shelf.